Hexoprenaline

Known as: 1,2-Benzenediol, 4,4'-(1,6-hexanediylbis(imino(1-hydroxy-2,1-ethanediyl)))bis-, Hexoprenaline [Chemical/Ingredient] 
Stimulant of adrenergic beta 2 receptors. It is used as a bronchodilator, antiasthmatic agent, and tocolytic agent.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
BACKGROUND Infantile haemangioma (IH) is the most commonly observed tumour in children. Off-label pharmacological treatment of IH… (More)
Is this relevant?
2004
2004
OBJECTIVE The aim of this study was to compare the efficacy and side effect profile of atosiban with hexoprenaline when used for… (More)
  • table 1
  • table 2
Is this relevant?
1993
1993
External cephalic versions in the study period were performed in a double blind design by 2 experienced practitioners. Sixty… (More)
Is this relevant?
1993
1993
Hexoprenaline is aβ-adrenergic agent used for tocolysis after the 26th week of pregnancy. The purpose of the present study was to… (More)
Is this relevant?
1991
1991
Despite the widespread use of beta-sympathomimetic agents for preterm labour there appears to be a limited appreciation of the… (More)
Is this relevant?
1985
1985
Hexoprenaline is a selective beta 2-mimetic drug used in tocology for the prevention of premature labor and immature birth. From… (More)
Is this relevant?
1983
1983
The limiting factor in the treatment of preterm labor by betamimetics is the effect of these drugs on heart rate and cardiac… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1979
1979
The effects of a treatment with a new beta2-adrenergic agent (hexoprenaline, Etoscol) as well as a combined therapy of… (More)
Is this relevant?
1977
1977
The bronchodilator effects of aerosols of hexoprenaline (200 microgram and 400 microgram), and salbutamol (200 microgram) were… (More)
Is this relevant?
1976
1976
A study was undertaken to compare the uterine beta2-adrenoreceptor selectivity of fenoterol, hexoprenaline, ritodrine and… (More)
Is this relevant?